There is a huge boom in the Medical sensors market. In 2012, the market was worth $8 billion, with biosensors contributing more than 60% of the total revenue. Much of the growth in the consumer wearable sector is driven by smartwatches and health and fitness trackers. There are no doubts regarding the huge potential of this market, and many companies have already shifted their attention towards this market. Let us look at some of the promising start-ups in this sector.
Also known as DNA Medicine Institute, this group based out of Cambridge, Massachusetts designed the “rHEALTH” system. The Reusable Handheld Electrolyte and Lab Technology is a portable, compact device that uses a single drop of blood to perform hundreds of clinical lab tests, telling patients whether they have anything from the common cold to Ebola. In fact, the rHEALTH sensor has undergone testing in lunar and zero gravity flights at the NASA space centre in Houston, Texas – where it performed without fail.
- Eigen Lifescience
Eigen Lifescience was created by four students and two faculty advisors from Stanford University. This medical company devised a Hepatitis B rapid blood test that can be analysed in minutes using the microprocessor on a smartphone. Designed for usage in developing countries, the test can detect patients who need treatment the most, for instance, a child with a Hepatitis B-infected mother must be treated within a time frame of 12 hours.
- Endotronix Wireless Health Monitoring
This company was founded in June 2007 by a cardiothoracic surgeon, Anthony Nunez, and a mechanical engineer, Harry Rowland. Endotronix has patented a new type of wireless sensor reader, intended to increase the quality of life, as well as lower the costs for those who suffer from congestive heart failure and other cardiac disorders.
The VSM (Vital Sign Monitoring) platform launched by the Switzerland-based company can simply be strapped to the upper arm, thereby collecting a vast amount of data regarding areas such as temperature, blood oxygenation, movement and activity, heart rate etc. That data can then be uploaded to the cloud and viewed on a smartphone or computer.
The London-based company launched AcuPebble, a tiny device that monitors for apnoea by capturing acoustic signals from the respiratory tract. This device was mainly intended for those with epilepsy; prevent sudden unexpected death in epilepsy. However, the device can also provide continuous remote monitoring of cardiac or respiratory conditions.
- Archimej Technology
This company, which began as the Alpha-Project in Shanghai in 2012 designed a device that can complete a comprehensive blood analysis with a few drops of the patient’s blood. It also tracks results over time, provides feedback, and allows patients to share their results with the doctors. This product offers the potential for health-conscious folks to add blood chemistry to their ever-growing mix of vital signs that can be had with a small sensor device.
- Golden Gopher Magnetic Biosensing
Researchers from the Mayo Clinic, University of Minnesota and several companies with an interest in biosensors came together to devise a user-friendly, portable and low-cost device, known as the GMR biosensing system was launched by this company and helps in detection of biomarkers in human serum and urine. Known as Z-lab, this highly sensitive sensor is now in development for smaller, more portable models.
SensoDx was founded in 2014 by Dr. John T. McDevitt, who is currently the Chair of the Biomaterials Department at New York University. This new medical micro-device company offers a wide array of tests, based on chip-based diagnostic devices at a reasonable fee. These diagnostics include trauma, ovarian cancer, oral cancer, drugs of abuse, cardiac heart disease, and prostate cancer. This device provides the results in minutes, rather than weeks.
Fatal pregnancy problems are the fear of every expecting woman and her family; Hemolix, which was developed at the University of South Florida provides technology that detects HELLP syndrome, a form of severe preeclampsia that can be threatening to both the mother and the child. With the help of this low-cost device, patients can get a rapid and accurate measurement of blood plasma haemoglobin concentration and helps in detecting the HELLP syndrome.
Diabetic retinopathy is the world’s leading cause of blindness; This company focuses on retinal imaging that costs much less than the alternative methods, thus empowering the diabetic patients to do their own screenings at a much lower price. This has the potential to be a game-changer in the developing countries, as it provides people an opportunity to evaluate their own optical health. This technology was developed at MIT Media Lab’s Camera Culture Group.
The future looks promising in this industry, as these devices have the potential to revolutionize the entire medical industry and the way in which patients are treated. Check out the Market Data Forecast’s Medical Devices category for comprehensive reports with in-depth analysis. Follow the blog for more interesting updates about medical devices